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Summary As a proportion of AIDS-defining illnesses, Kaposi's sarcoma (KS) decreased from 1987-89 to 1993-94 in homosexual and
bisexual men in all European regions and in the United States. Albeit underestimated, AIDS KS rates in the general male population at ages
25-49 are higher than those of the majority of cancer sites in the same age group.
Keywords: Kaposi's sarcoma; AIDS; incidence
A steady decline, in terms of the percentage of Kaposi's sarcoma
(KS) as an AIDS-defining illness, was first reported among homo-
sexual and bisexual men in the United States (US) (Des Jarlais et al,
1987). The broadening of the definition of an AIDS case in 1987 does
not entirely explain this decline, as it persists when analyses of trends
are restricted to KS and Pneumocystis carinii (i.e. two conditions that
have always been part of AIDS definition) (Beral et al, 1990).
The relative decline in KS was confirmed in AIDS surveillance
data or clinical series in several developed countries, such as
the United Kingdom (UK) (Peters et al, 1991), Germany
(Schwartlander et al, 1992), Italy (Serraino et al, 1992) and
Australia (Elford et al, 1993). It is at least partly attributed to the
shorter latency period between HIV infection and KS onset than in
other AIDS-defining illnesses (Hermans et al, 1996). According to
some investigators (Elford et al, 1993; Dore et al, 1996), however,
the relative decrease in KS might reflect a reduced prevalence
and/or virulence of the postulated KS agent following the adoption
of safer sexual practices by homosexual men.
Up to the end of 1994, approximately 440 000 AIDS cases had
been recorded in official data in the US and about 140 000 in
Europe. About 20% of AIDS patients had KS at the time of
presentation. It is therefore possible to review systematically
recent trends in KS in major European regions, and to assess sepa-
rately non-homosexual men and women, groups that were little
studied in the early phase of the epidemic on account of the low
frequency of the disease. Finally, in order to quantify the minimum
size of the epidemic of AIDS-associated KS at a population level,
age-standardized incidence rates have been computed from AIDS
surveillance data.
MATERIALS AND METHODS
Official AIDS notification numbers from 1987 to 1994 for coun-
tries belonging to World Health Organization (WHO) European
Region were derived from the European Non-Aggregate AIDS
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Data Set (ENAADS), updated to June 1995. Data for the US were
derived from the AIDS Public Information Data Set, updated to
December 1994. AIDS notifications include, among other items,
information on age group, sex, AIDS-defining illness(es) (Centers
for Disease Control and Prevention, 1987, 1992; Ancelle-Park,
1992) and HIV transmission group of each case. For the present
report, all AIDS cases in which KS was mentioned, alone or
in combination with opportunistic infections, were considered.
Homosexual and bisexual men who reported injected drug use
were included in the homosexual and bisexual group, whereas all
other modes of HIV transmission were categorized as non-homo-
sexual men. More details about these data sources are available
elsewhere (Dal Maso et al, 1995).
The comparability between European and US data has been
hampered since 1993 by the case definition change in the US
(i.e. reliance also on immunological criteria, < 200 CD4+ l-t%),
(Ancelle-Park, 1992; Centers for Disease Control and Prevention,
1992). Although, in principle, US surveillance data using a case
definition similar to the European one can be obtained after the
change, a concurrent or prior KS diagnosis might not have been
reported accurately. Thus, US data for 1993 and 1994 must be
interpreted with caution and considered as minimum KS estimates.
European countries were divided into four regions: (1) north
(Denmark, Iceland, Ireland, The Netherlands, Norway, Sweden
and the UK); (2) central (Austria, Belgium, France, Germany and
Switzerland); (3) south (Greece, Israel, Italy, Portugal and Spain);
(4) east (Croatia, Czech Republic, Hungary, Poland, Romania,
Slovakian Republic and Slovenia).
Sex-specific incidence rates of KS as an AIDS-defining illness
at all ages and in young adults (i.e. 25-49 years) were also
computed for various European countries and the US. In order to
correct for reporting delay, the method described by Rosenberg
(1990) was used for the last 20 three-month periods in each
country. Direct age standardization was carried out using the world
standard population.
RESULTS
Table 1 shows numbers and percentages of KS as an AIDS-
defining illness in four European regions and in the US by ethnic
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Table 1 Number and percentage of Kaposi's sarcoma as an AIDS-defining illness by year of diagnosis among homosexual or bisexual men, non-homosexual
men and women in European regions and the United States, 1987-1994
Year of diagnosis
1987-89 1990-92 1993-94 2
(trend)
Group Area Cases (%) Cases (%) Cases (%)
Homosexual or bisexual men Europe North 702 (20) 878 (18) 552 (17) 9.8a
Central 2484 (29) 3136 (28) 1743 (25) 46.1a
South 639 (26) 1110 (24) 723 (21) 22.1a
East 15 (17) 9 (6) 6 (4) 9.8a
United States White 10122 (22) 10666 (19) 2339 (15) 430.6a
Black 1259 (10) 1685 (9) 545 (8) 29.8a
Other 1710 (20) 2262 (18) 641 (14) 74.6a
Non-homosexual men Europe North 24 (3) 57 (4) 33 (3) 0.4
Central 249 (6) 338 (5) 223 (4) 11.3a
South 214 (3) 430 (3) 367 (3) 1.7
East 4 (2) 8 (1) 9 (1) 0.4
United States White 282 (4) 504 (5) 223 (5) 7.9a
Black 297 (3) 478 (2) 218 (2) 3.3
Other 229 (3) 397 (4) 141 (3) 0.4
Women Europe North 4 (2) 24 (4) 23 (3) 1.0
Central 50 (2) 74 (2) 49 (2) 3.4
South 40 (2) 63 (1) 76 (2) 0.0
East 1 (1) 6 (1) 4 (1) 1.0
United States White 48 (2) 65 (1) 21 (1) 3.3
Black 96 (2) 150 (1) 65 (1) 6.2b
Other 50 (2) 72 (2) 30 (1) 1.9
From AIDS surveillance data. ap < 0.01. bp < 0.05.
Table 2 Number and annual incidence rates per million of Kaposi's sarcoma as an AIDS-defining illness (AIDS-KS) by year of diagnosis and sex in selected
European countries and the United States, 1987-94
Annual incidence rate per milliona
All ages 25-49 yrs
Country (no. AIDS-KS) 1987-89 1990-92 1993-94 1987-89 1990-92 1993-94
Men
Austria (107) 2.2 3.7 3.1 5.9 9.1 8.6
Belgium (245) 4.1 5.8 6.1 11.3 16.3 17.7
Denmark (189) 6.8 8.5 7.8 17.8 21.8 20.9
France (5778) 18.4 24.3 25.2 47.6 64.9 67.6
Germany (2149) 5.5 5.1 4.3 14.5 13.2 11.5
Greece (131) 1.4 3.6 3.9 4.1 9.2 10.1
Italy (1453) 3.7 6.0 7.8 9.6 16.0 20.4
Netherlands (451) 5.7 7.5 4.9 16.1 20.4 12.8
Portugal (329) 4.6 7.9 12.1 11.8 19.3 28.7
Spain (1920) 6.6 13.0 15.2 17.4 33.2 39.0
Sweden (117) 3.2 3.5 2.0 8.9 8.9 6.0
Switzerland (543) 14.9 17.2 16.5 38.5 45.2 42.4
United Kingdom (1526) 4.8 6.1 7.5 13.8 16.9 20.6
United States (29083) 28.5 30.3 16.3 77.8 84.6 44.4
Women
France (131) 0.3 0.6 0.6 0.7 1.4 1.5
Italy (99) 0.2 0.3 0.7 0.5 1.0 1.9
Spain (78) 0.3 0.4 0.8 0.7 0.7 1.8
United Kingdom (44) 0.0 0.3 0.3 0.0 0.4 1.0
United States (416) 0.3 0.4 0.4 0.8 1.1 1.1
From AIDS surveillance data, adjusted for reporting delay. aAge-standardized, world population.
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group, separately for homosexual and non-homosexual men, and
for women. Significant declines in the proportion of KS among
homosexual and bisexual men were noticed in all regions exam-
ined. Decreases were greatest among US whites (from 22% in
1987-89 to 15% in 1993-94). Throughout the period studied the
highest proportions of KS were observed in central Europe (from
29% in 1987-89 to 25% in 1993-94) and the lowest among US
blacks (10% and 8% respectively). Among non-homosexual men
changes over time were less clear: the proportion of KS declined
significantly in central Europe (from 6% in 1987-89 to 4% in
1993-94), whereas it increased slightly (from 4% to 5% respec-
tively) among US whites. Among women, the proportion of KS
ranged between 1% and 4%, and did not show variations, except
for a moderate but significant decline among US blacks (Table 1).
Incidence rates of KS as an AIDS-defining illness in the general
population are given in Table 2. In most countries, male rates
increased from 1987-89 to 1990-92, and then stabilized or declined.
Upward trends were still present in 1993-94 in Italy, Spain and the
UK. In 1993-94 the most elevated incidence rates were found in
France (25.2), Spain (15.2), Switzerland (16.5) and the US (16.3).
The lowest rates (< 4 per million males) were seen in Austria,
Greece and Sweden. Thus, a more than tenfold difference was
observed between the highest and the lowest incidence countries.
Incidence rates in women were 10 to 20 times lower than those
in men, but have increased (Table 2). In 1993-94, the highest rates
were recorded in Italy (0.7 per million) and Spain (0.8). On
account of the relatively young age of AIDS patients, 25- to 49-
year truncated rates were two- to threefold higher than all-age rates
in both sexes.
DISCUSSION
The present report shows that the proportion of KS as an AIDS-
defining illness was still decreasing in the early 1990s in Europe
and the US. This phenomenon is clear among homosexual and
bisexual men. Modest but significant declines emerged also,
however, among non-homosexual men in central Europe and black
women in the US.
In contrast, in the same period, in several well-defined cohorts
of HIV-infected individuals, the incidence of KS had remained
approximately stable (Jacobson et al, 1990; Munioz et al, 1993;
Montaner et al, 1994; Lundgren et al, 1995; Veugelers et al, 1995;
Hermans et al, 1996). Conversely, declines in the cumulative inci-
dence of KS from the early 1980s to the early 1990s were reported
in two cohorts of AIDS patients from San Francisco, US (Katz et
al, 1994), and Australia (Dore et al, 1996).
In agreement with the survey by Hermans et al (1996), the
highest percentages of KS at AIDS presentation were found in
central Europe. This applies to homosexual as well as non-
homosexual men but has no clear explanation, as systematic
surveys of KS-associated herpesvirus prevalence have not been
performed in Europe.
In order to estimate the impact of AIDS-associated KS at a
population level, we have presented also age-standardized inci-
dence rates. They show a greater than tenfold variation between
European countries, attributable chiefly to the different size of the
AIDS epidemic and the proportion of homosexual and bisexual
men among AIDS cases (Dal Maso et al, 1995).
These rates are probably underestimated. Overall, AIDS report in
developed countries is approximately 85% complete (Buehler et al,
1992). About one-third of KS in HIV-positive individuals develop
after AIDS diagnosis (Hoover et al, 1993). Furthermore, the
1993-94 incidence is influenced by the correction for reporting
delay, a procedure that is less reliable for the most recent period (Dal
Maso et al, 1995). It is, however, worth noting that estimated KS
incidence rates for the US are similar to the population-based rates
reported in the same period by the combination of Surveillance
Epidemiology and End Results collection areas (Kosary et al, 1995).
Given the persisting upward trends ol AIDS in the last decade,
the relative declines of KS as an AIDS-defining illness have not
prevented incidence rates from increasing at least up to the late
1980s (Biggar et al, 1989; Chow et al, 1989; Rabkin and Yellin,
1994; Kosary et al, 1995). AIDS-associated KS have thus attained,
in men of the most affected developed countries, rates at all ages
comparable to those of cancer of the bone, connective tissues or
thyroid (Parkin et al, 1992). In young male adults (i.e. < 50 years),
rates of AIDS-associated KS in the early 1990s were similar to
incidence rates, for instance, of cancer of the testis, brain,
Hodgkin's disease or leukaemia and higher than those of the
majority of other neoplasms in the same age group (Levi et al,
1995). However, the incidence of AIDS-associated KS, even in the
highest risk developed countries, such as France, Spain or the US,
remained much lower than in Central Africa, where rates in men
exceeded 250 per million (Wabinga et al, 1993; Bassett et al, 1995).
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